Citation Tools

Original research
Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis

Download to a citation manager

Cite this article as:
Samadder NJ, Foster N, McMurray RP, et al
Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis